StonvexLoading…
StonvexCore line items from PR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.39B | $5.07B | $3.90B | $2.57B |
Operating Income | $467.25M | $1.46B | $1.19B | $801.95M |
Net Income | $43.62M | $935.17M | $595.67M | $536.43M |
EPS (Diluted) | $0.05 | $1.28 | $0.83 | $0.72 |
Total Assets | $17.99B | $17.91B | $17.33B | $17.49B |
Total Liabilities | $6.67B | $6.38B | $6.05B | $6.59B |
Cash & Equivalents | $170.78M | $153.69M | $111.81M | $451.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 827.96M | 751.75M | 720.74M | 747.24M |